Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,390,464
+$779,947 QoQ
Shares Held
1,993
+13.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#2,337
of 4,605 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Founders Financial Alliance, LLC holds $16,023,148 across 10 Drug Manufacturers - General names. LLY ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,208 | $4,330,221 | |
| 2 | JNJ |
Johnson & Johnson
|
16,743 | $4,252,219 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,993 | $2,390,464 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,983 | $2,053,815 | |
| 5 | AMGN |
Amgen Inc
|
2,252 | $815,494 | |
| 6 | PFE |
Pfizer Inc
|
33,547 | $807,811 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,222 | $531,371 | |
| 8 | AZN |
Astrazeneca PLC
|
1,540 | $292,014 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,390,464 | 1,993 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,610,517 | 1,751 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,890,362 | 1,759 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,338,302 | 1,754 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,464,736 | 1,879 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,577,488 | 1,910 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,217,444 | 1,577 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,670,882 | 1,886 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,924,837 | 2,126 | Shares | Sole | 2024-08-26 | |
| 2024-03-31 | $1,654,720 | 2,127 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,199,066 | 2,057 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,473,884 | 2,744 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,368,014 | 2,917 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $936,849 | 2,728 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $964,354 | 2,636 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $771,189 | 2,385 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $837,161 | 2,582 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $684,424 | 2,390 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $652,984 | 2,364 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $538,114 | 2,329 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $548,310 | 2,389 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $424,444 | 2,272 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $363,503 | 2,153 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $309,361 | 2,090 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||